Abstract
Introduction: Tuberculosis (TB) is a non-degenerative disease, which has a high negative health impact on both developed as well as developing countries. HIV, AIDS has increased the chance of TB occurrence.
Highlights
Tuberculosis (TB) is a non-degenerative disease, which has a high negative health impact on both developed as well as developing countries
Clients with Human Immune Deficiency Virus (HIV) are increasingly infected with tuberculosis because, HIV/Acquired Immune Deficiency Syndrome (AIDS) affects their immunity against diseases [5,6,7,8,9,10,11]; because HIV/AIDS fuels the tuberculosis epidemics in many ways, such as promoting progression to active tuberculosis, increasing the risk of reactivation of latent tuberculosis infection, as well as increasing chance of tuberculosis infection once exposed to tubercle bacilli [1,12]
This in significant variation on the magnitude of tuberculosis in HIV/AIDS patients may be due to differences regarding HIV infection rate in the population, availability of TB diagnostic facilities, and health care awareness of the community to seek health care for both TB and HIV
Summary
Tuberculosis (TB) is a non-degenerative disease, which has a high negative health impact on both developed as well as developing countries. HIV, AIDS has increased the chance of TB occurrence. Tuberculosis (TB) is highly common opportunistic infection and the leading cause of death in HIV patients in developing countries, and shares the burden about 40% of all manifestations seen in HIV patients. Tuberculosis (TB) and Human Immune Deficiency Virus (HIV) have been associated the emergence of Acquired Immune Deficiency Syndrome (AIDS) [1]. Human Immuno Deficiency Virus (HIV) increases susceptibility to infection with the risk of progression to TB disease. Developing countries like sub Saharan Africa where high prevalence of (HIV/AIDS) burden found, the TB Case Notification Rate (CNR) has increased four to six folds [3,4]. The Global report of 2013 showed that (13%)of the infection were reported for TB patients in the African region, among these 41% of those with an HIV test result
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
